METTL3 and hepatocellular carcinoma: Moreover, METTL3-mediated m6A modification could decrease the expression of suppressor of cytokine signaling 2 in HCC cells, thereby contributing to aggressive phenotype in vitro and in vivo (Chen et al., 2018).